Sheehan J P, Seelig M S
Magnesium. 1984;3(4-6):301-14.
The interactions of Mg and K in cardiovascular disease are diverse and complex. However, Mg deficiency and loss from the heart and arteries, caused e.g. by dietary deficiency or imbalance, or by diseases and their treatment, can contribute to cardiovascular damage, and to functional abnormalities. Although Mg deficiency interferes with K retention, it is seldom measured in routine clinical practice, and the need to correct low Mg levels, in order to replete K, is rarely considered. The heart, with its high metabolic activity, is particularly vulnerable to Mg deficiency or loss because of the importance of Mg in mitochondrial structure and enzymatic function. The need for Mg to activate Na/K ATPase has long been known. Mg has also been shown to be structurally part of the enzyme in cardiac mitochondria. Additionally, Na/K exchange occurs in association with phosphorylation and dephosphorylation, reactions that are also Mg-dependent. The demonstration that Mg modulates K+/proton (H+) exchange, and that cation selectivity in Na+ and K+ exchange for H+ is highly dependent on the concentration of Mg++, provides new insights into how Mg protects against K loss. The loss of myocardial K that results from Mg deficiency contributes to electrophysiologic changes, as can the Ca shifts of Mg loss. A high Ca/Mg ratio also predisposes to arterial spasms, and increases catecholamine release. Thus the arrhythmogenic potential of Mg deficiency can be related to imbalances between Mg and K or between Mg and Ca, or both. Electrical or K-induced catecholamine release is increased by a low Mg/Ca ratio, as are increased fatty acids and lipids and intravascular hypercoagulability. K or Ca loading of the patient with undiagnosed Mg inadequacy is not only often unsuccessful, but it may carry inherent risks. It can intensify the Mg depletion, the arterial contractility, and ECG abnormality. In the patient receiving digitalis, Mg deficiency can increase drug toxicity. In the case of myocardial infarction, Mg deficiency can increase the risk of malignant ventricular arrhythmias and sudden cardiac death. In the absence of alcoholism or gastrointestinal disease, the use of loop diuretic therapy for congestive heart failure, especially in elderly patients, is the most common cause of Mg depletion. A high concurrence of hypomagnesemia with hypokalemia, from whatever cause, has been documented. However, systemic Mg deficiency can exist despite normal Mg serum levels. Methodological difficulties hamper direct detection of cellular Mg deficiency, but patients can be indirectly evaluated by use of Mg-loading tests, which may be of combined diagnostic and therapeutic value.(ABSTRACT TRUNCATED AT 400 WORDS)
镁(Mg)和钾(K)在心血管疾病中的相互作用多种多样且复杂。然而,镁缺乏以及因饮食缺乏或不均衡、疾病及其治疗等导致的心脏和动脉中的镁流失,会促成心血管损伤和功能异常。尽管镁缺乏会干扰钾的潴留,但在常规临床实践中很少对其进行检测,而且为补充钾而纠正低镁水平的必要性也很少被考虑。心脏具有高代谢活性,由于镁在线粒体结构和酶功能中的重要性,它特别容易受到镁缺乏或流失的影响。长期以来人们都知道激活钠/钾ATP酶需要镁。镁还被证明是心脏线粒体中该酶的结构组成部分。此外,钠/钾交换与磷酸化和去磷酸化相关联,而这些反应也依赖于镁。镁调节钾离子/质子(H⁺)交换的证明,以及钠和钾与氢离子交换中的阳离子选择性高度依赖于镁离子(Mg²⁺)浓度,为镁如何防止钾流失提供了新的见解。镁缺乏导致的心肌钾流失会导致电生理变化,镁流失引起的钙转移也会如此。高钙/镁比值还易引发动脉痉挛,并增加儿茶酚胺释放。因此,镁缺乏的致心律失常潜力可能与镁和钾之间或镁和钙之间的失衡,或两者皆有关。低镁/钙比值会增加电刺激或钾诱导的儿茶酚胺释放,脂肪酸和脂质增加以及血管内高凝状态也是如此。对未诊断出镁缺乏的患者进行钾或钙负荷治疗不仅常常不成功,而且可能存在内在风险。它会加剧镁耗竭、动脉收缩力和心电图异常。在接受洋地黄治疗的患者中,镁缺乏会增加药物毒性。在心肌梗死的情况下,镁缺乏会增加恶性室性心律失常和心源性猝死的风险。在没有酗酒或胃肠道疾病的情况下使用袢利尿剂治疗充血性心力衰竭,尤其是在老年患者中,是镁耗竭最常见的原因。无论何种原因,低镁血症与低钾血症的高并发情况都有记录。然而,尽管血清镁水平正常,全身性镁缺乏仍可能存在。方法学上的困难阻碍了细胞镁缺乏的直接检测,但可以通过镁负荷试验对患者进行间接评估,该试验可能具有诊断和治疗双重价值。(摘要截选至40字)